IGF2BP2 and colitis: After 7 d 2.5% DSS administration, IGF2BP2–/– mice displayed more severe colitis compare with WT mice, associated with faster rate of body weight loss, higher disease activity index (DAI) (Figure 5b) and tinier colon length (Figure 5c).